Recommendations in 2014 – osteoarthritis Review article

Main Article Content

Witold Tłustochowicz

Abstract

The article is based on existing international recommendations. It presents the pathogenesis and clinical factors leading to the formation of osteoarthritis. Non-pharmacological and pharmacological methods were described and safety aspects were taken into account.

Article Details

How to Cite
Tłustochowicz , W. (2014). Recommendations in 2014 – osteoarthritis. Medycyna Faktow (J EBM), 7(2(23), 66-72. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2370
Section
Articles

References

1. Scanzello C., Plaas A., Crow M.: Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr. Opin. Rheumatol. 2008; 20: 565-572.
2. Osteoarthritis. Care and management in adults Issued: February 2014. NICE clinical guideline 177 guidance.nice.org.uk/cg177.
3. Haugen I., Englund M., Aliabadi P. et al.: Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann. Rheum. Dis. 2011; 70: 1581-1586.
4. Klimiuk P., Kuryliszyn-Moskal A.: Choroba zwyrodnieniowa stawów. W: Puszczewicz M. Wielka Interna, Medical Tribune Polska.
5. Bos S., Slagboom P., Meulenbelt I.: New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr. Opin. Rheumatol. 2008; 20: 553-559.
6. Pottie B., Presle N., Terlain B. et al.: Obesity and osteoarthritis: more complex than predicted! Ann. Rheum. Dis. 2006; 65(11): 1403.
7. Fernandes L., Hagen K., Bijlsma J. et al.: EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann. Rheum. Dis. 2013; 72: 1125-1135.
8. Zhang W., Moskowitz R., Nuki G. et al.: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidencebased, expert consensus guidelines. Osteoarthritis and Cartilage 2008; 16: 137-162.
9. Zhang W., Doherty M., Leeb B. et al.: EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2007; 66: 377-388.
10. Zhang W., Doherty M., Arden N. et al.: EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 2005; 64: 669-681.
11. Scheiman J., Sidote D.: Which NSAID for your patients with osteoarthritis. J. Fam. Pract. 2010; 59(11): E1-6.
12. Liorente Melero M., Tenias Burilloy J., Zaragoza Marcet A.: Comparaciondel riesgo de hemorriagia digestive alta asociado diferentes anti – inflamatorios no esteroides. Revista Española do Enfermedades Digestivas 2002; 94: 7-12.
13. Diaz C., Rodriguez de la Serna A., Gell C., Gras X. et al.: Efficacy and tolerability aceclofenac versus diclofenac in thetratment of knee osteoarthritis: a multicentre study. Eur. J. of Rheumatol. Inflamm. 1996, 1(16).
14. Kornasoff D., Frerick H., Bowdler J., Montull E.: Aceclofenac is well-tolerated alternative to naproksen in the treatment of osteoarthritis. Clinical Rheumatology 1997; 16: 132-138.
15. Woroń J.: Racjonalne stosowanie niesteroidowych leków przeciwzapalnych w terapii bólu. Medycyna Praktyczna 2012; 9.
16. Lapeyre-Mestre M., Grolleau S., Montastruc J.: Adverse drug reaction associated with the use of NSAIDs a case/noncase analysis of spontaneus reports from French pharmacovigilance database 2002–2006. Fundamental & Clinical Pharmacology 2011.
17. F.J. de Abajo, M.J. Gil, P. Garcia Poza, V. Bryant, O. Belen, J. Timoner, L.A. Garcia-Rodriguez: Risk of nonfatal acute myocardial infarction associated with nonsteroidal antiinflammatory drugs, non-narcotic analgesics and other drug used in osteoarthritis, a nested case-control study: Pharmacoepidemiology and Drug Safety 2014.
18. H. Bueno, A. Bardaji, P. Patrignani, E. Martin-Merino, L.A. Garcia Rodriguez: Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome: Am. J. Cardiol. 2010; 105: 1102-1106.
19. Blot L., Marcelis A., Devogelaer J., Manicourt D.: Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronian in osteoarthritic human cartilage. Brit. J. Pharmacol. 2000; 131: 1413-1421.